Study: ‘Genetic Vaccines Must Be Pulled’

Seven Australian authors “advocate for the suspension of gene-based COVID-19 vaccines … and other vaccines based on mRNA or viral-vector DNA technology.”

Perspectives on Health

People frequently ask me for “comprehensive” publications on vaccine side effects. The SARS-CoV-2 Spike protein is present in the virus, and it is uncontrollably produced by the mRNA and adenoviral DNA COVID-19 vaccines. Because the vaccines failed to prevent COVID-19, the majority of vaccinated people became ill, resulting in multiple spike protein exposures.

Parry et al. published a comprehensive review on the plethora of spike protein diseases that arise as a result of its widespread distribution in the body. Some of their evidence-based teaching points are as follows:
“SARS-CoV-2 spike protein is pathogenic, whether from the virus or created from genetic code in mRNA and adenovector DNA vaccines.”Data from a rodent biodistribution study show that lipid nanoparticles transport mRNA to all organs and cross the blood-brain and blood-placenta barriers. Because some of these tissues are unlikely to be resistant to viral infection, the biohazard stems primarily from vaccination.”Inflammatory properties of lipid nanoparticles”The modification of mRNA with N1-methylpseudouridine for increased stability results in spike protein production for months. Because it is unknown how many cells and organs produce mRNA spike proteins, the exact effective dose delivered per vaccine vial is unknown.”At the moment, the long-term fate of mRNA within cells is unknown.””mRNA and adenovector DNA vaccines function as’synthetic viruses.'”The encoding-based COVID-19 vaccines will likely transfect a far more diverse set of tissues than infection by the virus itself in the young and healthy, and even in many older individuals with vulnerable comorbidities.Evidence suggests that mRNA can be reverse-transcribed into a DNA copy. This raises the prospect of intergenerational transmission if germline cells incorporate the DNA copy into the host genome.Foreign protein production on cell surfaces, such as spike protein, can trigger autoimmune responses and tissue damage. This has serious implications for any future mRNA-based drug or vaccine.”The spike protein causes pathophysiological effects (‘spikeopathy’) through a variety of mechanisms, including inflammation, thrombogenesis, endotheliitis-related tissue damage, and prion-related dysregulation.The interaction of the vaccine-encoded spike protein with ACE-2, P53, and BRCA1 suggests a broad range of biological interference with oncological potential.Data from official pharmacovigilance databases, as well as an FDA-Pfizer report obtained through FOI, show high rates of adverse events and multiple organ systems affected: primarily neurological, cardiovascular, and reproductive.The clinical trial data for the Pfizer and Moderna mRNA COVID-19 vaccines has been independently interpreted and published to show an unfavorable risk/benefit, particularly in the non-elderly. “Clearly, the risks outweigh the benefits for children.”Booster doses of COVID-19 vaccine appear to induce tolerance and may contribute to recurrent COVID-19 infection and ‘long COVID.’
“The SARS-CoV-2 pandemic has revealed deficiencies in public health and medicines regulatory agencies.”For what appears to be a hurried response to an alarming infectious disease pandemic, a root cause analysis is required.
“Treatment modalities for ‘spikeopathy’-related pathology in many organ systems, require urgent research and provision to millions of sufferers of long-term COVID-19 vaccine injuries.”

[From the conclusion of the review authors:]
“We also advocate for a moratorium on gene-based COVID-19 vaccines and lipid-nanoparticle carrier matrices, as well as other vaccines based on mRNA or viral-vector DNA technology.” A safer option is to use vaccines based on well-tested recombinant protein, attenuated or inactivated virus technologies, of which there are now many for SARS-CoV-2 vaccination.”
Reposted with permission from Peter A. McCullough Substack